Reuters logo
6 months ago
BRIEF-Maverick and Takeda announce 5 year collaboration to advance T-cell engagement therapies
January 11, 2017 / 1:38 PM / 6 months ago

BRIEF-Maverick and Takeda announce 5 year collaboration to advance T-cell engagement therapies

1 Min Read

Jan 11 (Reuters) - Takeda Pharmaceutical Co Ltd

* Maverick Therapeutics and Takeda announce five-year collaboration to advance T-cell engagement therapies

* Takeda invests $125 million in Maverick, including exclusive option-to-acquire

* Deal provides Takeda exclusive right to purchase Maverick after five years for an undisclosed sum Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below